GlassScriptPhysician profile
Abubaker Abdalla
NPI 1194187617
$46,881.70
in general payments reported to CMS, 2019-2025
11 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $161 · 2024: $4,261 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $38K · Travel and Lodging: $6,518 · Food and Beverage: $2,815 · Education: $48.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $37,500.00 |
| Travel and Lodging | $6,517.62 |
| Food and Beverage | $2,815.13 |
| Education | $48.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $44,751.23 | 2024-2025 | General - Therapies, General - Endochoice, Overstitch Endoscopic Suturing System |
| Ovesco Endoscopy USA, INC. | $834.50 | 2025 | |
| Olympus Corporation of The Americas | $274.89 | 2024 | Disposable Distal Attachment, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Micro-Tech Endoscopy USA, INC. | $258.34 | 2024 | |
| Olympus America INC. | $212.22 | 2024-2025 | Visiglide, Single Use Electrosurgical Knife Kd-655 |
| Abiomed | $166.07 | 2024 | Impella |
| Janssen Scientific Affairs, LLC | $111.76 | 2023 | Stelara |
| Cook Medical LLC | $110.05 | 2025 | Echotip Insight |
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Janssen Biotech, INC. | $48.95 | 2023 | Tremfya, Stelara |
| Abbvie INC. | $28.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abubaker Abdalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.